Capmatinib efficacy in patients with NSCLC identified as METex14 using an NGS-based liquid biopsy assay: Results from the GEOMETRY mono-1 study.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Massachusetts General Hospital, University of California, Los Angeles, National Cancer Centre Singapore, University Medical Center Groningen, University of Groningen, National Hospital Organization Kyushu Cancer Center, The Netherlands Cancer Institute, University of Cologne, University Hospital Cologne
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novartis
OpenAlex ID: W3168085080
